About the job
For over 25 years, Corcept Therapeutics has dedicated itself to exploring the science of cortisol, a potent hormone whose dysregulation can contribute to a wide array of diseases.
Our extensive commercial portfolio features innovative treatments for hypercortisolism and oncology, alongside the discovery of more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With ongoing advanced clinical trials targeting patients with hypercortisolism, solid tumors, ALS, and liver disease, Corcept is pioneering the potential of cortisol modulation to tackle some of the most challenging health issues faced by patients today.
Located in Redwood City, California, we invite you to discover more about our mission and work at www.corcept.com.

